Hosted on MSN

BD announces wearable injector trial for subcutaneous delivery of biologics

Becton, Dickinson and Company (BD) has announced a trial utilising the BD Libertas wearable injector for subcutaneous delivery of biologics. The decision to employ the injector in this first ...
The Business Journals

Researchers develop wearable patch for early skin cancer detection

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Researchers at Wake Forest University School of Medicine ...
Nasdaq

BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs

FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination ...
EurekAlert!

Researchers develop wearable patch for early skin cancer detection

WINSTON-SALEM, N.C., Oct. 22, 2025 — Researchers at Wake Forest University School of Medicine have developed a groundbreaking, battery-free wearable patch that could help detect skin cancer earlier ...